期刊文献+

ACLY在结肠癌组织中的表达及其临床意义 被引量:8

下载PDF
导出
摘要 目的:探索ATP柠檬酸裂解酶(ACLY)在结肠癌组织中的表达情况及其临床病理学意义,为结肠癌的诊治提供新思路。方法:以50例结肠癌患者为研究对象,用免疫组织化学染色方法观察结肠癌患者的癌组织及对应的癌旁组织标本中ACLY的表达,并研究ACLY表达的临床病理学意义。结果:在结肠癌组织中ACLY表达显著高于对应的癌旁组织(P=0);ACLY高表达与结肠癌的浸润深度、淋巴结转移及TNM分期显著相关(P值分别为0、0.005及0.007);与年龄、性别、肿瘤大小、组织分化程度无相关性(P>0.05)。结论:ACLY在结肠腺癌组织中高表达,且与肿瘤转移相关;ACLY有望成为结肠癌诊治的一个新靶点。
作者 张金倩 陈洪
出处 《东南大学学报(医学版)》 CAS 北大核心 2017年第6期962-965,共4页 Journal of Southeast University(Medical Science Edition)
  • 相关文献

参考文献4

二级参考文献52

  • 1Jin H, Wang X, Ying J, Wong AH, Cui Y, Srivastava G, Shen ZY, Li EM, Zhang Q, Jin J, Kupzig S, Chan AT, Cullen PJ, Tao Q. Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers. Proc Natl Acad Sci U S A 2007; 104:12353-12358.
  • 2Ohta M, Seto M, Ijichi H, Miyabayashi K, Kudo Y, Mohri D, Asaoka Y, Tada M, Tanaka Y, Ikenoue T, Kanai F, Kawabe T, Omata M. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.Gastroenterology 2009; 136:206-216.
  • 3Bernards A, Settleman J. Loss of the Ras regulator RASALI: another route to Ras activation in colorec- tal cancer. Gastroenterology 2009; 136:46-48.
  • 4Fromowitz FB, Viola MV, Chao S, Oravez S, Mishriki Y, Finkel G, Grimson R, Lundy J. ras p21 expres- sion in the progression of breast cancer. Hum Pathol 1987; 18:1268-1275.
  • 5Westbrook TF, Martin ES, Schlabach MR, Leng Y, Liang AC, Feng B, Zhao JJ, Roberts TM, Mandel G, Hannon GJ, Depinho RA, Chin L, Elledge SJ. A genetic screen for candidate tumor suppressors identifies REST. Cell 2005; 121:837-848.
  • 6Alien M, Chu S, Brill S, Stotler C, Buckler A. Restricted tissue expression pattern of a novel human rasGAP-related gene and its murine ortholog. Gene 1998; 218:17-25.
  • 7Chen Y, KnOsel T, Ye F, Pacyna-Gengelbach M, Deutschmann N, Petersen I. Decreased PITX1 ho- meobox gene expression in human lung cancer. Lung Cancer 2007; 55:287-294.
  • 8Kolfschoten IG, van Leeuwen B, Berns K, Muilen- ders J, Beijersbergen RL, Bernards R, Voorhoeve PM, Agami R. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 2005; 121:849-858.
  • 9Muallem S. Decoding Ca2+ signals: a question of timing. J Cell Bio12005; 170:173-175.
  • 10Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A, Pandit B, Oishi K, Martinelli S, Schackwitz W, Ustaszewska A, Martin J, Bristow J, Carta C, Lepri F, Neri C, Vasta I, Gibson K, Curry CJ, Siguero JP, Digilio MC, Zampino G, Dallapiccola B, Bar-Sagi D, Gelb BD. Gain-of-function SOS1 mutatiolls cause a distinctive form of Noonan syndrome. Nat Genet 2007; 39:75-79.

共引文献14

同被引文献75

引证文献8

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部